Mariah Baltezegar is a senior leader within the peri- and post-approval studies (PPAS) group, responsible for the performance, growth and development of virtual trial approaches and associated integrated solu- tions. She has worked in various clinical research capacities for the past 20 years, including a proven 17-year history in operations and business procurement. Baltezegar also has 13 years of experience working in various capacities in the complex space of rare disease development. Baltezegar completed her Master of Business Administration at the University of North Carolina, Wilmington, and holds a bachelor’s degree in psychology with a minor in statistics from Winona State University.